<scp>PD</scp> ‐L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti‐ <scp>PD</scp> ‐1/ <scp>PD</scp> ‐ <scp>L</scp> 1 clinical trials
Summary This study evaluated the expression of PD ‐ L 1 in immunotherapy‐naïve metastatic melanoma patients to determine longitudinal intrapatient concordance and correlate PD ‐...